Justin Ritz

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 51 papers. Top paper: “Symptom and Viral Rebound in Untreated SARS-CoV-2 Infection”.

Symptom and Viral Rebound in Untreated SARS-CoV-2 Infection

Annals of Internal Medicine(2023)10.7326/m22-2381

N/A

2.0DataRank · unranked

63 citations

Manish C. Choudhary, Carlee Moser, Justin Ritz, Eric S. Daar, David A. Wohl +41 more

Emergence of SARS-CoV-2 escape mutations during Bamlanivimab therapy in a phase II randomized clinical trial

Nature Microbiology(2022)10.1038/s41564-022-01254-1

N/A

1.6DataRank · unranked

53 citations

Kara W Chew, Rinki Deo, James P. Flynn, James Regan, Charles R. Crain +51 more

Safety and Efficacy of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies Amubarvimab Plus Romlusevimab in Nonhospitalized Patients With COVID-19

Annals of Internal Medicine(2023)10.7326/m22-3428

N/A

0.785DataRank · unranked

31 citations

Kara W Chew, Mark J Giganti, Carlee Moser, Mauricio Pinilla, David A. Wohl +76 more

Bamlanivimab reduces nasopharyngeal SARS-CoV-2 RNA levels but not symptom duration in non-hospitalized adults with COVID-19

medRxiv(2021)10.1101/2021.12.17.21268009

N/A

0.626DataRank · unranked

14 citations

Carlee Moser, Eric S. Daar, David A. Wohl, Jonathan Z. Li, Robert W. Coombs +18 more

One Week of Oral Camostat Versus Placebo in Nonhospitalized Adults With Mild-to-Moderate Coronavirus Disease 2019: A Randomized Controlled Phase 2 Trial

Clinical Infectious Diseases(2023)10.1093/cid/ciad342

N/A

0.622DataRank · unranked

19 citations

Kara W Chew, Mark J Giganti, Eric S. Daar, David A. Wohl, Arzhang Cyrus Javan +47 more

Bamlanivimab therapy for acute COVID-19 does not blunt SARS-CoV-2–specific memory T cell responses

JCI Insight(2022)10.1172/jci.insight.163471

N/A

0.587DataRank · unranked

13 citations

Alba Grifoni, Daniela Weiskopf, Urvi M. Parikh, Amy Heaps, Farhoud Faraji +15 more

Safety and efficacy of inhaled interferon-β1a (SNG001) in adults with mild-to-moderate COVID-19: a randomized, controlled, phase II trial

EClinicalMedicine(2023)10.1016/j.eclinm.2023.102250

N/A

0.587DataRank · unranked

12 citations

Kara W Chew, Mark J Giganti, Michael D. Hughes, Carlee Moser, Mark Main +79 more

Nasal and Plasma Severe Acute Respiratory Syndrome Coronavirus 2 RNA Levels Are Associated With Timing of Symptom Resolution in the ACTIV-2 Trial of Nonhospitalized Adults With Coronavirus Disease 2019

Clinical Infectious Diseases(2022)10.1093/cid/ciac818

N/A

0.583DataRank · unranked

10 citations

Linda J Harrison, Kara W Chew, Judy Currier, David A. Wohl, Eric S. Daar +12 more

Novel Criteria for Diagnosing Acute and Early Human Immunodeficiency Virus Infection in a Multinational Study of Early Antiretroviral Therapy Initiation

Clinical Infectious Diseases(2020)10.1093/cid/ciaa1893

N/A

0.556DataRank · unranked

14 citations

Justin Ritz, Robert W. Coombs, Lu Zheng, Joseph J. Eron, John W. Mellors +31 more

Immune Status and SARS-CoV-2 Viral Dynamics

The Journal of Infectious Diseases(2023)10.1093/infdis/jiad200

N/A

0.550DataRank · unranked

13 citations

Carlee Moser, Evgenia Aga, Judith S. Currier, David A. Wohl, Eric S. Daar +30 more

Early antiviral CD4+ and CD8+ T cells are associated with upper airway clearance of SARS-CoV-2

JCI Insight(2024)10.1172/jci.insight.186078

N/A

0.540DataRank · unranked

13 citations

Paul Lopez, Farhoud Faraji, Urvi M. Parikh, Amy Heaps, Justin Ritz +17 more

Safety and Efficacy of Combined Tixagevimab and Cilgavimab Administered Intramuscularly or Intravenously in Nonhospitalized Patients With COVID-19

JAMA Network Open(2023)10.1001/jamanetworkopen.2023.10039

N/A

0.490DataRank · unranked

11 citations

Kara W Chew, Carlee Moser, Judith S. Currier, Joseph J. Eron, Arzhang Cyrus Javan +47 more

Statistical Challenges When Analyzing SARS-CoV-2 RNA Measurements Below the Assay Limit of Quantification in COVID-19 Clinical Trials

(2023)10.1093/infdis/jiad285

N/A

0.475DataRank · unranked

7 citations

Kara W Chew, Mark J Giganti, Jonathan Z. Li, Evgenia Aga, Justin Ritz +24 more

Variant-Specific Viral Kinetics in Acute COVID-19

The Journal of Infectious Diseases(2023)10.1093/infdis/jiad314

N/A

0.395DataRank · unranked

5 citations

Manish C. Choudhary, Rinki Deo, Mark J Giganti, Carlee Moser, Justin Ritz +26 more

Pooling Different Placebos as a Control Group in a Randomized Platform Trial: Benefits and Challenges From Experience in the ACTIV-2 COVID-19 Trial

The Journal of Infectious Diseases(2023)10.1093/infdis/jiad209

N/A

0.344DataRank · unranked

8 citations

Kara W Chew, Justin Ritz, Matthew Newell, Arzhang Cyrus Javan, Joseph J. Eron +19 more

Validity and Characterization of Time to Symptom Resolution Outcome Measures in the ACTIV-2/A5401 Outpatient COVID-19 Treatment Trial

The Journal of Infectious Diseases(2023)10.1093/infdis/jiad300

N/A

0.270DataRank · unranked

3 citations

Carlee Moser, Eunice Yeh, David A. Wohl, Eric S. Daar, Justin Ritz +7 more

Post-acute COVID-19 outcomes including participant-reported long COVID: amubarvimab/romlusevimab versus placebo in the ACTIV-2 trial

EClinicalMedicine(2024)10.1016/j.eclinm.2024.102787

N/A

0.208DataRank · unranked

3 citations

Carlee Moser, Nikolaus Jilg, Justin Ritz, David A. Wohl, Jonathan Z. Li +89 more

SARS-CoV-2 Plasma Antibody and Nucleocapsid Antigen Status Predict Outcomes in Outpatients With COVID-19

Clinical Infectious Diseases(2024)10.1093/cid/ciae324

N/A

0.189DataRank · unranked

2 citations

Mark J Giganti, Kara W Chew, Kathryn Shaw‐Saliba, Justin Ritz, Carlee Moser +10 more

Safety and Efficacy of SAB-185 for Nonhospitalized Adults With COVID-19: A Randomized Clinical Trial

The Journal of Infectious Diseases(2024)10.1093/infdis/jiae369

N/A

0.165DataRank · unranked

2 citations

Babafemi Taiwo, Carlee Moser, Eric S. Daar, David A. Wohl, Justin Ritz +46 more

Tixagevimab/cilgavimab or placebo for COVID-19 in ACTIV-2: Safety, pharmacokinetics and neutralizing and anti-drug antibodies

iScience(2025)10.1016/j.isci.2025.111938

N/A

0.104DataRank · unranked

1 citations

Kara W Chew, Carlee Moser, Judith S. Currier, Joseph J. Eron, Arzhang Cyrus Javan +14 more

Discontinuation of tenofovir disoproxil fumarate from initial ART regimens because of renal adverse events: An analysis of data from four multi-country clinical trials

PLOS Global Public Health(2024)10.1371/journal.pgph.0002648

N/A

0DataRank · unranked

8 citations

Justin Ritz, Michael D. Hughes, Mitch Matoga, Mina C. Hosseinipour, McNeil Ngongondo

Characterization of Treatment Resistance and Viral Kinetics in the Setting of Single-Active Versus Dual-Active Monoclonal Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2

The Journal of Infectious Diseases(2024)10.1093/infdis/jiae192

N/A

0DataRank · unranked

7 citations

Rinki Deo, Teresa H. Evering, Kara W Chew, Mark J Giganti, Carlee Moser +17 more

Safety, Efficacy, and Pharmacokinetics of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies BMS-986414 (C135-LS) and BMS-986413 (C144-LS) Administered Subcutaneously in Non-Hospitalized Persons with COVID-19 in a Phase 2 Trial.

Pathogens and Immunity(2024)10.20411/pai.v9i1.660

N/A

0DataRank · unranked

0 citations

Kara W Chew, Mark J Giganti, Ying Mu, Courtney V. Fletcher, Judith S. Currier +12 more

Discontinuation of tenofovir disoproxil fumarate from initial ART regimens because of renal adverse events: An analysis of data from four multi-country clinical trials

UNC Libraries(2024)10.17615/912s-cf39

N/A

0DataRank · unranked

0 citations

Justin Ritz, Mina C. Hosseinipour, A AIDS Clinical Trials Group A, Michael D. Hughes, Mitch Matoga +1 more

Safety, Efficacy, and Pharmacokinetics of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies BMS-986414 (C135-LS) and BMS-986413 (C144-LS) Administered Subcutaneously in Non-Hospitalized Persons with COVID-19 in a Phase 2 Trial

UNC Libraries(2024)10.17615/14jx-sy24

N/A

0DataRank · unranked

0 citations

Carlee Moser, Mark J Giganti, Joseph J. Eron, Katya Corado, ACTIV- A Study Team +13 more

Viral and Symptom Rebound Following Anti–Severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Therapy in a Randomized Placebo-Controlled Trial

The Journal of Infectious Diseases(2024)10.1093/infdis/jiae501

N/A

0DataRank · unranked

0 citations

Brooke McGinley, Carlee Moser, Jonathan Z. Li, Teresa H. Evering, Justin Ritz +42 more

Implementation of a seamless phase 2/3 study design in the setting of an emergent infectious disease pandemic: Lessons learned from the ACTIV-2 platform COVID-19 treatment trial

Contemporary Clinical Trials(2025)10.1016/j.cct.2025.107887

N/A

0DataRank · unranked

1 citations

Kara W Chew, Carlee Moser, Joseph J. Eron, Mauricio Pinilla, Jonathan Z. Li +8 more

Early antiviral CD4+ and CD8+ T cells are associated with upper airway clearance of SARS-CoV-2

UNC Libraries(2025)10.17615/smh2-pc80

N/A

0DataRank · unranked

0 citations

Paul Klekotka, Alexander L. Greninger, Judith S. Currier, Chew K.W., Parikh U.M +16 more

Symptom and Viral Rebound in Untreated SARS-CoV-2 Infection

UNC Libraries(2025)10.17615/m8r8-hh40

N/A

0DataRank · unranked

0 citations

Judith S. Currier, Kara W Chew, Carlee Moser, Manish C. Choudhary, Michael D. Hughes +9 more

Safety and Efficacy of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies Amubarvimab Plus Romlusevimab in Nonhospitalized Patients With COVID-19

UNC Libraries(2025)10.17615/ryrv-wq75

N/A

0DataRank · unranked

0 citations

Yan Li, Jonathan Z. Li, Rachel Bender Ignacio, Kara W Chew, Bharat Mocherla +23 more

Impact of antiretroviral therapy during acute or early HIV infection on virologic and immunologic outcomes: results from a multinational clinical trial

UNC Libraries(2025)10.17615/617b-mq21

N/A

0DataRank · unranked

0 citations

Cecilia Kanyama, Lu Zheng, Joseph J. Eron, Javier R. Lama, Justin Ritz +22 more

Safety and Efficacy of SAB-185 for Non-hospitalized Adults with COVID-19: A Randomized Clinical Trial

UNC Libraries(2025)10.17615/h4dx-ze98

N/A

0DataRank · unranked

0 citations

Luke, Thomas, David A. Wohl, Alexander L. Greninger, Christoph Bausch, Davey M. Smith +16 more

HIV Salvage Therapy Does Not Require Nucleoside Reverse Transcriptase Inhibitors: A Randomized, Controlled Trial

The Research Repository @ WVU (West Virginia University)(2020)10.17615/sc4s-7473

N/A

0DataRank · unranked

1 citations

Carl J. Fichtenbaum, Karen T. Tashima, Joseph J. Eron, Richard Haubrich, Karin L. Klingman +8 more

Structure-Function Model for Kissing Loop Interactions That Initiate Dimerization of Ty1 RNA

UNC Libraries(2020)10.17615/fb5q-hd04

N/A

0DataRank · unranked

0 citations

Justin Ritz, Eric Gamache, Alain Laederach, Jung H. Doh, Stanislav Bellaousov +2 more

Emergence of SARS-CoV-2 Resistance with Monoclonal Antibody Therapy

medRxiv(2021)10.1101/2021.09.03.21263105

N/A

0DataRank · unranked

21 citations

Kara W Chew, Rinki Deo, James P. Flynn, James Regan, Charles R. Crain +23 more

Monoclonal antibody treatment drives rapid culture conversion in SARS-CoV-2 infection

medRxiv(2021)10.1101/2021.12.25.21268211

N/A

0DataRank · unranked

6 citations

Kara W Chew, Manish C. Choudhary, Rinki Deo, James Regan, James P. Flynn +20 more

Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19

Nature Communications(2022)10.1038/s41467-022-32551-2

N/A

0DataRank · unranked

49 citations

Carlee Moser, Eric S. Daar, David A. Wohl, Jonathan Z. Li, Robert W. Coombs +21 more

Predictors of SARS-CoV-2 RNA From Nasopharyngeal Swabs and Concordance With Other Compartments in Nonhospitalized Adults With Mild to Moderate COVID-19

Open Forum Infectious Diseases(2022)10.1093/ofid/ofac618

N/A

0DataRank · unranked

14 citations

Jonathan Z. Li, Joseph J. Eron, Evgenia Aga, Eric S. Daar, David A. Wohl +29 more

Monoclonal antibody treatment drives rapid culture conversion in SARS-CoV-2 infection

Cell Reports Medicine(2022)10.1016/j.xcrm.2022.100678

N/A

0DataRank · unranked

20 citations

Kara W Chew, Manish C. Choudhary, Rinki Deo, James Regan, James P. Flynn +19 more

Viral and Symptom Rebound in Untreated COVID-19 Infection

medRxiv(2022)10.1101/2022.08.01.22278278

N/A

0DataRank · unranked

21 citations

Manish C. Choudhary, Carlee Moser, Justin Ritz, Eric S. Daar, David A. Wohl +9 more

Bamlanivimab therapy for acute COVID-19 does not blunt SARS-CoV-2-specific memory T cell responses

UNC Libraries(2022)10.17615/473v-1p84

N/A

0DataRank · unranked

0 citations

Urvi M. Parikh, Judith S. Currier, Shane Crotty, Carlee Moser, Alessandro Sette +14 more

Predictors of virologic outcome among people living with HIV who continue a protease inhibitor-based antiretroviral regimen following virologic failure with no or limited resistance

AIDS Research and Therapy(2023)10.1186/s12981-022-00494-9

N/A

0DataRank · unranked

1 citations

Beatriz Grinsztejn, Justin Ritz, Ann C. Collier, Evelyn Hogg, Robert Gross +8 more

Early antiviral CD4 and CD8 T cell responses and antibodies are associated with upper respiratory tract clearance of SARS-CoV-2

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.10.25.564014

N/A

0DataRank · unranked

3 citations

Paul Lopez, Farhoud Faraji, Urvi M. Parikh, Amy Heaps, Justin Ritz +17 more

Statistical Challenges when Analyzing SARS-CoV-2 RNA Measurements Below the Assay Limit of Quantification in COVID-19 Clinical Trials

medRxiv(2023)10.1101/2023.03.13.23287208

N/A

0DataRank · unranked

2 citations

Kara W Chew, Mark J Giganti, Jonathan Z. Li, Evgenia Aga, Justin Ritz +10 more

Predictors of SARS-CoV-2 RNA From Nasopharyngeal Swabs and Concordance With Other Compartments in Nonhospitalized Adults With Mild to Moderate COVID-19

UNC Libraries(2023)10.17615/vptt-dg28

N/A

0DataRank · unranked

0 citations

Arzhang Cyrus Javan, Joseph J. Eron, Justin Ritz, Judith S. Currier, Prasanna Jagannathan +12 more

Emergence of SARS-CoV-2 escape mutations during Bamlanivimab therapy in a phase II randomized clinical trial

UNC Libraries(2023)10.17615/s90c-rs31

N/A

0DataRank · unranked

0 citations

Jonathan Z. Li, Paul Klekotka, James P. Flynn, Joseph J. Eron, Justin Ritz +23 more

Nasal and Plasma Severe Acute Respiratory Syndrome Coronavirus 2 RNA Levels Are Associated With Timing of Symptom Resolution in the ACTIV-2 Trial of Nonhospitalized Adults With Coronavirus Disease 2019

UNC Libraries(2023)10.17615/x7r0-1v04

N/A

0DataRank · unranked

0 citations

Joseph J. Eron, Kara W Chew, Michael D. Hughes, Carlee Moser, Judy Currier +12 more

Nasal and Plasma SARS-CoV-2 RNA Levels are Associated with Timing of Symptom Resolution in the ACTIV-2 Trial of Non-hospitalized Adults with COVID-19

UNC Libraries(2023)10.17615/ra63-p116

N/A

0DataRank · unranked

0 citations

Jonathan Z. Li, Carlee Moser, Arzhang Cyrus Javan, Judy Currier, Michael D. Hughes +12 more

Impact of antiretroviral therapy during acute or early HIV infection on virologic and immunologic outcomes: results from a multinational clinical trial

AIDS(2024)10.1097/qad.0000000000003881

N/A

0DataRank · unranked

18 citations

Justin Ritz, Lu Zheng, Asma Naqvi, Joshua C. Cyktor, Joseph Puleo +21 more

SARS-CoV-2 Monoclonal Antibody Treatment Followed by Vaccination Shifts Human Memory B-Cell Epitope Recognition, Suggesting Antibody Feedback

The Journal of Infectious Diseases(2024)10.1093/infdis/jiae371

N/A

0DataRank · unranked

13 citations

Sydney I. Ramirez, Hallie Cohn, Urvi M. Parikh, Amy Heaps, Scott F. Sieg +22 more

Sirolimus reduces T cell cycling, immune checkpoint marker expression, and HIV-1 DNA in people with HIV

Cell Reports Medicine(2024)10.1016/j.xcrm.2024.101745

N/A

0DataRank · unranked

9 citations

Ronald J. Bosch, Catherine Godfrey, Hanna Mar, Apsara Nair, Michael C. Keefer +28 more